Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multi-centre cohort study.
Wu W, Guo B, Sun W, Chen D, Xu W, Chen Z, Fu Y, Ye Y, Lyu X, Xue Z, Wang K, Zhao J, Xie C, Chen Y, Ye C, Dai M, Fan W, Li J, Wang X, Xue Y, Wan W, Sun L, Wu H, Luo Q, Han Q, Fu Q, Ye S.
Wu W, et al. Among authors: xu w.
Eur Respir J. 2025 Jan 30:2401488. doi: 10.1183/13993003.01488-2024. Online ahead of print.
Eur Respir J. 2025.
PMID: 39884766